Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Neovasc Inc. NVCN

Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter... see more

NDAQ:NVCN - Post Discussion

Neovasc Inc. > BS analyst forcasts
View:
Post by pdesj2000 on Apr 24, 2018 7:44am

BS analyst forcasts

I think what bothers me the most about this whole dilution process is that after everything 
that happened, most analysts still maintain that this is a strong buy. After looking at their firecasts
over the last 2-3 years, no wonder people are losing money. They have been totally off since the beginning.
Comment by Sanderz on Apr 24, 2018 9:20am
I agree, Analysts' target prices don't mean anything!   Just because they give a target price does not mean it WILL be that price.  I can give this ANY target price I want, even if it's within reason, does that mean it will happen? Nope.     I've said this many times before, I've yet to see any "target price" actually happen.    ...more